Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat
Authors
Keywords
-
Journal
Nature Communications
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-01-12
DOI
10.1038/s41467-017-02677-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Understanding the Physiology of FGF21
- (2016) Ffolliott Martin Fisher et al. Annual Review of Physiology
- A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects
- (2016) Saswata Talukdar et al. Cell Metabolism
- Protein Inhibitor of Activated STAT 1 (PIAS1) Protects Against Obesity-Induced Insulin Resistance by Inhibiting Inflammation Cascade in Adipose Tissue
- (2015) Yang Liu et al. DIABETES
- Maintenance of Subcutaneous Fat Homeostasis Improves Systemic Metabolic Dysfunction in Obesity
- (2015) Ippei Shimizu et al. DIABETES
- A Novel Role for Subcutaneous Adipose Tissue in Exercise-Induced Improvements in Glucose Homeostasis
- (2015) Kristin I. Stanford et al. DIABETES
- FGF21 and the late adaptive response to starvation in humans
- (2015) Pouneh K. Fazeli et al. JOURNAL OF CLINICAL INVESTIGATION
- Circulating FGF21 Is Liver Derived and Enhances Glucose Uptake During Refeeding and Overfeeding
- (2014) K. R. Markan et al. DIABETES
- Fibroblast growth factor 21 protects against acetaminophen-induced hepatotoxicity by potentiating peroxisome proliferator-activated receptor coactivator protein-1α-mediated antioxidant capacity in mice
- (2014) Dewei Ye et al. HEPATOLOGY
- Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients
- (2014) J M Gallego-Escuredo et al. INTERNATIONAL JOURNAL OF OBESITY
- Inventing new medicines: The FGF21 story
- (2014) Alexei Kharitonenkov et al. Molecular Metabolism
- FGF21 as a Stress Hormone: The Roles of FGF21 in Stress Adaptation and the Treatment of Metabolic Diseases
- (2014) Kook Hwan Kim et al. Diabetes & Metabolism Journal
- UCP1 mRNA does not produce heat
- (2013) Jan Nedergaard et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes
- (2013) Gregory Gaich et al. Cell Metabolism
- Adiposity and Insulin Resistance in Humans: The Role of the Different Tissue and Cellular Lipid Depots
- (2013) Samantha Hocking et al. ENDOCRINE REVIEWS
- Increased fibroblast growth factor 21 expression in high-fat diet-sensitive non-human primates (Macaca mulatta)
- (2013) E B Nygaard et al. INTERNATIONAL JOURNAL OF OBESITY
- Fibroblast growth factor 21 protects against cardiac hypertrophy in mice
- (2013) A. Planavila et al. Nature Communications
- Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications
- (2013) Norbert Stefan et al. Lancet Diabetes & Endocrinology
- Fibroblast Growth Factor-21 Regulates PPARγ Activity and the Antidiabetic Actions of Thiazolidinediones
- (2012) Paul A. Dutchak et al. CELL
- βKlotho Is Required for Fibroblast Growth Factor 21 Effects on Growth and Metabolism
- (2012) Xunshan Ding et al. Cell Metabolism
- TNF-α Represses β-Klotho Expression and Impairs FGF21 Action in Adipose Cells: Involvement of JNK1 in the FGF21 Pathway
- (2012) Julieta Díaz-Delfín et al. ENDOCRINOLOGY
- FGF21 regulates PGC-1 and browning of white adipose tissues in adaptive thermogenesis
- (2012) f. M. Fisher et al. GENES & DEVELOPMENT
- MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity
- (2012) Christine M Kusminski et al. NATURE MEDICINE
- FGF21 Promotes Metabolic Homeostasis via White Adipose and Leptin in Mice
- (2012) Murielle M. Véniant et al. PLoS One
- Treating Diabetes and Obesity with an FGF21-Mimetic Antibody Activating the Klotho/FGFR1c Receptor Complex
- (2012) I. N. Foltz et al. Science Translational Medicine
- Adiponectin Enhances Insulin Sensitivity by Increasing Hepatic IRS-2 Expression via a Macrophage-Derived IL-6-Dependent Pathway
- (2011) Motoharu Awazawa et al. Cell Metabolism
- Lack of Overt FGF21 Resistance in Two Mouse Models of Obesity and Insulin Resistance
- (2011) Clarence Hale et al. ENDOCRINOLOGY
- β-Arrestin-1 Protein Represses Diet-induced Obesity
- (2011) Le-nan Zhuang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Preferential Fat Deposition in SubcutaneousVersusVisceral Depots Is Associated with Insulin Sensitivity
- (2011) Tracey McLaughlin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Location, location, location: Beneficial effects of autologous fat transplantation
- (2011) Sarang N. Satoor et al. Scientific Reports
- Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State
- (2010) f. M. Fisher et al. DIABETES
- Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease
- (2010) Jody Dushay et al. GASTROENTEROLOGY
- Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride
- (2010) Huating Li et al. JOURNAL OF HEPATOLOGY
- Fibroblast Growth Factor 21-Deficient Mice Demonstrate Impaired Adaptation to Ketosis
- (2009) Michael K. Badman et al. ENDOCRINOLOGY
- Fibroblast Growth Factor 21 Regulates Lipolysis in White Adipose Tissue But Is Not Required for Ketogenesis and Triglyceride Clearance in Liver
- (2009) Yuhei Hotta et al. ENDOCRINOLOGY
- Deficiency of a β-arrestin-2 signal complex contributes to insulin resistance
- (2009) Bing Luan et al. NATURE
- FGF21 induces PGC-1 and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response
- (2009) M. J. Potthoff et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Optimal waist circumference cutoffs for abdominal obesity in Chinese
- (2008) Yuqian Bao et al. ATHEROSCLEROSIS
- Beneficial Effects of Subcutaneous Fat Transplantation on Metabolism
- (2008) Thien T. Tran et al. Cell Metabolism
- Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity
- (2008) M. Mraz et al. CLINICAL ENDOCRINOLOGY
- Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans
- (2008) X. Zhang et al. DIABETES
- Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice
- (2008) J. Xu et al. DIABETES
- Fibroblast Growth Factor 21 Corrects Obesity in Mice
- (2008) Tamer Coskun et al. ENDOCRINOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More